# Foundation Medicine

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/foundation-medicine/

## Facts

| Field | Value |
| --- | --- |
| Country | US |
| Description | American genomics company |
| OpenAlex ID | https://openalex.org/F4320334461 |
| Works | 1,764 |

## Funder papers

- [<i>EGFR</i> -Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes](https://scholariq.org/papers/i-egfr-i-mutant-adenocarcinomas-that-transform-to-small-cell-lung-cancer-and/)
- [Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study](https://scholariq.org/papers/durvalumab-in-combination-with-olaparib-in-patients-with-relapsed-sclc-results/)
- [Integrative Analysis of a Large Real-World Cohort of Small Cell Lung Cancer Identifies Distinct Genetic Subtypes and Insights into Histologic Transformation](https://scholariq.org/papers/integrative-analysis-of-a-large-real-world-cohort-of-small-cell-lung-cancer-2/)
- [HEPATOTOXICITY AND ABSORPTION OF EXTRAHEPATIC ACETALDEHYDE IN RATS](https://scholariq.org/papers/hepatotoxicity-and-absorption-of-extrahepatic-acetaldehyde-in-rats/)
- [Integrative analysis of a large real-world cohort of small cell lung cancer identifies distinct genetic subtypes and insights into histological transformation](https://scholariq.org/papers/integrative-analysis-of-a-large-real-world-cohort-of-small-cell-lung-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.